Luye Pharma founded its predecessors.
The revenue of Luye Pharma exceeded RMB 100 million
Luye Pharma Intellectual Property Department and
the International Cooperation Department were established.
Established the "Golden Leaf medal” system to recognize
the Luyers who work and grew up with the company.
The Luye Pharma R&D Center was established.
Luye Pharma first landed in the international
capital market, listed in Singapore.
Luye Pharma acquired Nanjing Kanghai,
Nanjing Sike and Beijing Peking University WBL,
strengthening the oncology and cardiovascular product line.
Luye Pharma acquired Sichuan Baoguang Pharmaceutical,
to strengthen the endocrine and metabolic system product line.
The solid preparation production line of Luye Pharma passed
the EU GMP inspection.
Several innovative preparations and new drugs were
registered in the U.S. for clinical research.
Luye Pharma was listed on the Main Board of Hong Kong
Luye Pharma's self-developed microsphere product
LY03004 completed all registered clinical research in the U.S.
Luye Medical acquired Healthe Care,
Australia's third largest private hospital group.
The international development has taken a solid step.
Luye Pharma acquired Europe's leading
transdermal drug delivery Business
Luye Medical acquired Singapore OncoCare Cancer Center
Luye Group officially changed its name to
"Luye Life Sciences Group"
Boston R&D Center was put into operation,
laying a solid technical foundation through collaboration
on new platforms and projects,
to help ensure the sustainable pipeline development.
Through a serious Acquisition, Healthe Care increased
the number of hospitals to 35 and expanded into New Zealand.
Luye Medical acquired Singapore Novena Heart Center
Healthe Care voted the 14th best company to work for in Australia
alongside Apple, Virgin Australia, and Nestle.
(Randstad’s annual Employer Brand Research Report)
Luye Pharma acquired the business of Seroquel
in 51 Countries and Regions from AstraZeneca
Luye Medical and Cleveland Clinic announced
strategic cooperation, planning to constract
"Luye Medical -Cleveland Clinic Connected” hospital in Shanghai
Healthe Care Australian surgical firsts: Minimally invasive
spinal surgery and 3D technology at Gosford Private;
Orthopaedic rehabilitation pilot to streamline pre/post-operative
and create real time patient experience outcome measures.
The Group creates a new brand system,
marking a new era in building an international life sciences group